(Q33285706)

25 July 2017

title

Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma (English)

1 reference

25 July 2017

Cheng-Shyong Chang

1

1 reference

25 July 2017

Julia H Chang

2

1 reference

25 July 2017

Nicholas C Hsu

3

1 reference

25 July 2017

Hsuan-Yu Lin

4

1 reference

25 July 2017

Chih-Yuan Chung

5

1 reference

25 July 2017

language of work or name

English

0 references

publication date

24 May 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

7

1 reference

25 July 2017

page(s)

88

1 reference

Creative Commons Attribution 2.0 Generic

25 July 2017

copyright license

start time

24 May 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Endogenous expression of CD80 co-stimulatory molecule facilitates in vivo tumor regression of oral squamous carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888700

Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888700

Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888700

CD28/B7 system of T cell costimulation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888700

Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888700

B70 antigen is a second ligand for CTLA-4 and CD28.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888700

Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888700

B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888700

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888700

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival

28 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-7-88

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-7-88

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17524139

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Increased production of interferon-gamma by tumour infiltrating T lymphocytes in nasopharyngeal carcinoma: indicative of an activated status

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17524139

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-7-88

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference